ES2069902T3 - Analisis de variante de analito. - Google Patents

Analisis de variante de analito.

Info

Publication number
ES2069902T3
ES2069902T3 ES91914885T ES91914885T ES2069902T3 ES 2069902 T3 ES2069902 T3 ES 2069902T3 ES 91914885 T ES91914885 T ES 91914885T ES 91914885 T ES91914885 T ES 91914885T ES 2069902 T3 ES2069902 T3 ES 2069902T3
Authority
ES
Spain
Prior art keywords
variants
population
pct
fractionation system
analyte
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91914885T
Other languages
English (en)
Inventor
Erling Sundrehagen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Axis Biochemicals AS
Original Assignee
Axis Biochemicals AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26297237&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2069902(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB909013895A external-priority patent/GB9013895D0/en
Priority claimed from GB919102024A external-priority patent/GB9102024D0/en
Application filed by Axis Biochemicals AS filed Critical Axis Biochemicals AS
Application granted granted Critical
Publication of ES2069902T3 publication Critical patent/ES2069902T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/538—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by sorbent column, particles or resin strip, i.e. sorbent materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/964—Chemistry: molecular biology and microbiology including enzyme-ligand conjugate production, e.g. reducing rate of nonproductive linkage
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Devices For Executing Special Programs (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

LA INVENCION SUMINISTRA UN METODO PARA EL ENSAYO DE LA CONCENTRACION DE UN CONJUNTO DE VARIANTES EN UNA POBLACION DE VARIANTES DE SUBSTANCIAS PROTEINACEAS CAPACES DE SEPARARSE MEDIANTE UN SISTEMA DE FRACCIONACION, EN EL QUE DICHA POBLACION DE VARIANTES SE PONE EN CONTACTO CON UNA POBLACION DE COMPAÑEROS PROTEINACEOS ETIQUETADOS DE UNION ESPECIFICA PARA LAS MISMAS PARA FORMAR COMPLEJOS DE SUBSTANCIAS-COMPAÑEROS ETIQUETADOS CON LOS MISMOS, QUE SE EXPONEN ENTONCES A SU SEPARACION MEDIANTE DICHO SISTEMA DE FRACCIONACION EN UNA O MAS FRACCIONES QUE CONTIENEN DICHO CONJUNTO DE VARIANTES DE SUBSTANCIAS EN FORMA COMPLEJADA Y SE MIDE LA CANTIDAD DE ETIQUETAS EN UNA O MAS FRACCIONES ASI OBTENIDAS, DICHA POBLACION DE COMPAÑEROS DE UNION ESPECIFICA, TIENEN, ANTES DE LA REACCION, UNA DISTRIBUCION O UNA MOVILIDAD SUBSTANCIALMENTE UNIFORME EN DICHO SISTEMA DE FRACCIONANCION, ASIMISMO SE PRESENTAN COMPOSICIONES Y EQUIPOS DE PRUEBA PARA SU USO EN TALES METODOS. EL METODO DE LA INVENCION ES PARTICULARMENTE ADECUADO PARA EL ANALISIS DE VARIANTES DE LA TRANSFERRINA DE LA PROTEINA.
ES91914885T 1990-06-21 1991-06-20 Analisis de variante de analito. Expired - Lifetime ES2069902T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909013895A GB9013895D0 (en) 1990-06-21 1990-06-21 Analyte variant analysis
GB919102024A GB9102024D0 (en) 1991-01-30 1991-01-30 Analyte variant analysis

Publications (1)

Publication Number Publication Date
ES2069902T3 true ES2069902T3 (es) 1995-05-16

Family

ID=26297237

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91914885T Expired - Lifetime ES2069902T3 (es) 1990-06-21 1991-06-20 Analisis de variante de analito.

Country Status (15)

Country Link
US (1) US5352616A (es)
EP (1) EP0535162B1 (es)
JP (1) JP2517187B2 (es)
AT (1) ATE120551T1 (es)
AU (1) AU654497B2 (es)
CA (1) CA2085579A1 (es)
CZ (1) CZ283072B6 (es)
DE (1) DE69108554T2 (es)
DK (1) DK0535162T3 (es)
ES (1) ES2069902T3 (es)
FI (1) FI925781A (es)
HU (1) HU215555B (es)
NO (1) NO303852B1 (es)
SK (1) SK279009B6 (es)
WO (1) WO1991019983A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3978226B2 (ja) * 1991-09-25 2007-09-19 サーマル マクローフ アルコール中毒患者を同定しアルコール消費を監視するためのイムノアッセイ
US5843680A (en) * 1992-01-31 1998-12-01 Biometric Imaging, Inc. Differential separation assay methods and test kits
US5571729A (en) * 1992-06-17 1996-11-05 Wako Pure Chemical Industries, Ltd. Process for separating complex
SE501668C2 (sv) * 1993-08-06 1995-04-10 Biolin Medical Ab Kvantifiering av CD-transferrin vid hög alkoholkonsumtion med HPLC
DE4447334B4 (de) * 1994-12-31 2004-01-15 Karin Artelt-Zerfass Behandlungsgerät für medizinische und/oder therapeutische Anwendungen
EP0811166B1 (en) * 1995-02-22 1999-10-06 Axis Biochemicals ASA Carbohydrate-deficient transferrin assay
US5798212A (en) * 1995-02-22 1998-08-25 Axis Biochemicals Asa CDT assay
CA2181109A1 (en) 1995-07-18 1997-01-19 Nobuko Imajo Polypeptide and process for measuring living body components using the same
DE19543569C2 (de) * 1995-11-22 1998-01-22 Atou Lo Verwendung des Lectins Sambucus nigra zur Quantifizierung der endständigen Sialinsäurereste des Human-Transferrin-Moleküls mittels einer vollimmunoenzymatischen Methode (EIA)
SE9602234D0 (sv) * 1996-06-06 1996-06-06 Pharmacia Ab A novel diagnostic method utilizing ECP, and reagents to be used in the methods
AU8483698A (en) 1997-07-15 1999-02-10 Bioprobes, Inc. Determining alcohol intake using sialic acid/apo j
GB9827411D0 (en) * 1998-12-11 1999-02-03 Axis Biochemicals Asa Dipstick assay
GB9929308D0 (en) * 1999-12-10 2000-02-02 Axis Shield Plc Assay
US6255047B1 (en) * 2000-02-28 2001-07-03 Bio-Rad Laboratories, Inc. Biosynthetic carbohydrate-deficient transferrin references
AU2003268031A1 (en) * 2002-07-29 2004-02-16 Correlogic Systems, Inc. Quality assurance/quality control for electrospray ionization processes
US7691640B2 (en) * 2005-09-30 2010-04-06 Adeline Vanderver Biochemical marker for diagnosing a leukodystrophy
US20230296559A1 (en) * 2022-03-18 2023-09-21 Regeneron Pharmaceuticals, Inc. Methods and systems for analyzing polypeptide variants

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338396A (en) * 1976-10-06 1982-07-06 Kiyasu John Y Heart attack screening method and process
JPS59126246A (ja) * 1983-01-08 1984-07-20 Fuji Photo Film Co Ltd Ｄｎａもしくはｄｎａ部分分解物の塩基配列決定方法
SE440699B (sv) * 1984-02-06 1985-08-12 Pharmacia Ab Sett att medelst isotransferrinbestemning uppskatta en individs alkoholkonsumtion
JPH07113606B2 (ja) * 1986-10-27 1995-12-06 株式会社島津製作所 塩基配列決定装置
JPS6388747U (es) * 1986-11-28 1988-06-09
JP2594925B2 (ja) * 1987-01-23 1997-03-26 株式会社日立製作所 電気泳動装置
WO1988008984A1 (en) * 1987-05-12 1988-11-17 Coulter Electronics, Inc. Method and test kit for neutralization/immunoinhibition assay
AU626563B2 (en) * 1988-01-29 1992-08-06 Abbott Laboratories Ion-capture reagents and methods for performing binding assays
JP2686565B2 (ja) * 1989-12-25 1997-12-08 忠三 岸本 Ｃ／ｅｂｐ２遺伝子及びリコンビナントｃ／ｅｂｐ２

Also Published As

Publication number Publication date
EP0535162B1 (en) 1995-03-29
NO924912L (no) 1993-02-22
FI925781A0 (fi) 1992-12-18
JPH06502912A (ja) 1994-03-31
HU9204073D0 (en) 1993-04-28
CZ283072B6 (cs) 1997-12-17
AU654497B2 (en) 1994-11-10
WO1991019983A1 (en) 1991-12-26
SK279009B6 (sk) 1998-05-06
DE69108554D1 (de) 1995-05-04
NO303852B1 (no) 1998-09-07
NO924912D0 (no) 1992-12-18
AU8322891A (en) 1992-01-07
US5352616A (en) 1994-10-04
HU215555B (hu) 1999-01-28
HUT65621A (en) 1994-07-28
SK374392A3 (en) 1995-05-10
EP0535162A1 (en) 1993-04-07
CZ374392A3 (en) 1993-05-12
CA2085579A1 (en) 1991-12-22
JP2517187B2 (ja) 1996-07-24
FI925781A (fi) 1992-12-18
DK0535162T3 (da) 1995-06-12
ATE120551T1 (de) 1995-04-15
DE69108554T2 (de) 1995-08-31

Similar Documents

Publication Publication Date Title
ES2069902T3 (es) Analisis de variante de analito.
NO931747D0 (no) Fremgangsmaate ved undersoekelse av glycerte blodproteiner,samt anordning for utfoerelse av fremgangsmaaten
DK96689A (da) Fremgangsmaade til immunbestemmelse og diagnostisk middel til anvendelse ved fremgangsmaaden
SE9504046D0 (sv) Method of determining affinity and kinetic properties
NO903124L (no) Testmetode og reagenssett for denne.
DK622688A (da) Analysemetode og testsystem til bestemmelse af en analyt i en blodproeve
DE3580640D1 (de) Testverfahren.
DE60019111D1 (de) Verfahren zur zellseparation unter verwendung von immunorosetten
ATE209356T1 (de) Ein verfahren zur bestimmung von kollagenfragmenten in körperflüssigkeiten, ein testkit und mittel zur durchführung des verfahrens, und seine verwendung zur feststellung von mit dem kollagenmetabolismus assoziierten störungen
ES2118062T3 (es) Composiciones reactivas, metodos y reactivos para la valoracion cuantitativa de magnesio o de calcio y magnesio.
YU46053B (sh) Postopek za specifično določanje vsebnosti serumskega fruktozamina
ATE271220T1 (de) Borathaltige speicherpuffer und probenverdünner
ATE64784T1 (de) Einfarbenablesendes verfahren zur bestimmung vom fructosamin.
DK0402997T3 (da) Fremgangsmåde til bestemmelse af nukleinsyre
ATE43254T1 (de) Verfahren zur hemmung der reduktion des glucose- gehalts im blut.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 535162

Country of ref document: ES